1-20633737-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_032409.3(PINK1):​c.189C>T​(p.Leu63=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.187 in 1,537,436 control chromosomes in the GnomAD database, including 28,117 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.16 ( 2121 hom., cov: 32)
Exomes 𝑓: 0.19 ( 25996 hom. )

Consequence

PINK1
NM_032409.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -1.15
Variant links:
Genes affected
PINK1 (HGNC:14581): (PTEN induced kinase 1) This gene encodes a serine/threonine protein kinase that localizes to mitochondria. It is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations in this gene cause one form of autosomal recessive early-onset Parkinson disease. [provided by RefSeq, Jul 2008]
MIR6084 (HGNC:50235): (microRNA 6084) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 1-20633737-C-T is Benign according to our data. Variant chr1-20633737-C-T is described in ClinVar as [Benign]. Clinvar id is 262026.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-20633737-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-1.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.198 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PINK1NM_032409.3 linkuse as main transcriptc.189C>T p.Leu63= synonymous_variant 1/8 ENST00000321556.5 NP_115785.1
MIR6084NR_106732.1 linkuse as main transcriptn.59C>T non_coding_transcript_exon_variant 1/1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PINK1ENST00000321556.5 linkuse as main transcriptc.189C>T p.Leu63= synonymous_variant 1/81 NM_032409.3 ENSP00000364204 P1Q9BXM7-1
MIR6084ENST00000622012.1 linkuse as main transcriptn.59C>T non_coding_transcript_exon_variant 1/1

Frequencies

GnomAD3 genomes
AF:
0.156
AC:
23658
AN:
151890
Hom.:
2119
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0662
Gnomad AMI
AF:
0.198
Gnomad AMR
AF:
0.145
Gnomad ASJ
AF:
0.267
Gnomad EAS
AF:
0.140
Gnomad SAS
AF:
0.157
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.248
Gnomad NFE
AF:
0.201
Gnomad OTH
AF:
0.186
GnomAD3 exomes
AF:
0.176
AC:
23446
AN:
133556
Hom.:
2227
AF XY:
0.178
AC XY:
13042
AN XY:
73426
show subpopulations
Gnomad AFR exome
AF:
0.0662
Gnomad AMR exome
AF:
0.151
Gnomad ASJ exome
AF:
0.270
Gnomad EAS exome
AF:
0.149
Gnomad SAS exome
AF:
0.154
Gnomad FIN exome
AF:
0.179
Gnomad NFE exome
AF:
0.200
Gnomad OTH exome
AF:
0.201
GnomAD4 exome
AF:
0.190
AC:
263229
AN:
1385438
Hom.:
25996
Cov.:
36
AF XY:
0.190
AC XY:
129910
AN XY:
684130
show subpopulations
Gnomad4 AFR exome
AF:
0.0650
Gnomad4 AMR exome
AF:
0.151
Gnomad4 ASJ exome
AF:
0.265
Gnomad4 EAS exome
AF:
0.131
Gnomad4 SAS exome
AF:
0.153
Gnomad4 FIN exome
AF:
0.181
Gnomad4 NFE exome
AF:
0.198
Gnomad4 OTH exome
AF:
0.186
GnomAD4 genome
AF:
0.156
AC:
23651
AN:
151998
Hom.:
2121
Cov.:
32
AF XY:
0.153
AC XY:
11393
AN XY:
74308
show subpopulations
Gnomad4 AFR
AF:
0.0660
Gnomad4 AMR
AF:
0.145
Gnomad4 ASJ
AF:
0.267
Gnomad4 EAS
AF:
0.140
Gnomad4 SAS
AF:
0.157
Gnomad4 FIN
AF:
0.188
Gnomad4 NFE
AF:
0.201
Gnomad4 OTH
AF:
0.185
Alfa
AF:
0.192
Hom.:
704
Bravo
AF:
0.151
Asia WGS
AF:
0.134
AC:
464
AN:
3458

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 31, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 24% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 22. Only high quality variants are reported. -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 01, 2017- -
Autosomal recessive early-onset Parkinson disease 6 Benign:3
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 27, 2017- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 28, 2018- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
12
DANN
Benign
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs45530340; hg19: chr1-20960230; COSMIC: COSV58630221; COSMIC: COSV58630221; API